Degradable chemo bead treatment for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial studies a new type of “degradable” chemo bead delivered through a catheter to treat hepatocellular carcinoma (HCC). It aims to check safety and whether the treatment works when surgery or transplant is not an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 19 and 79 years old.
- You agree to join by signing an informed consent form.
- You have confirmed hepatocellular carcinoma (liver cancer) and at least one solid liver lesion larger than 1 cm—typically seen on MRI or contrast CT; if scans are unclear, a biopsy may be needed.
- Your liver function is Child-Pugh A or B (not C), and your cancer is not spread outside the liver or into major blood vessels.
- You can receive follow-up for at least 6 months, and your general condition is ECOG 0–1 (not greater than 1).
- You have no key exclusions like severe kidney disease, uncontrolled bleeding, uncontrolled fluid in the belly, or major MRI/CT/angiogram and contrast-medication problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment that delivers tiny radioactive beads directly to liver tumors through a tube. It is for people with one or a few small liver tumors that cannot be removed with surgery or destroyed with heat or cold. The goal is to shrink or control the tumors with fewer side effects.
This trial tests a combination of two treatments for advanced liver cancer that cannot be removed by surgery. One treatment delivers chemotherapy directly to the tumor, and the other uses tiny beads to block the tumor's blood supply. This approach may help shrink tumors and slow the cancer's growth.
This trial compares two types of tiny beads used in a liver cancer treatment called TACE to see which works better. If you have liver cancer that needs TACE and your liver is still working fairly well, you may be able to join.
This trial tests a combination of treatments for liver cancer that cannot be removed with surgery. It uses a procedure to block the tumor's blood supply plus two drugs that help the immune system fight the cancer. This may help shrink tumors and slow the disease.
This trial tests a new combination for liver cancer that cannot be surgically removed yet. It uses tiny radioactive beads (yttrium-90) to deliver radiation directly to the tumor, along with immunotherapy drugs and a targeted therapy to shrink the tumor, with the hope that it can later be surgically removed.
This trial is testing a low 'scout' dose of tiny radioactive beads (resin microspheres) given into the liver to treat liver cancer. The goal is to see if this approach is safe and helps patients with certain types of liver cancer that cannot be surgically removed.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.